Saudi Arabia Diabetes Drug Market Growth Forecast to 2030: Size & Demand Outlook

Saudi Arabia Diabetes Drug Market Overview and Insights:

According to Markntel Advisors Report, Saudi Arabia Diabetes Drug Market size was valued at around USD 2 billion in 2024 and is projected to reach USD 3.4 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period (2025-30).

Saudi Arabia Diabetes Drug Market research is an ongoing process. Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.

Download Report Sample PDF - https://www.marknteladvisors.com/query/request-sample/saudi-arabia-diabetes-drug-market.html

Industry Growth Driver:

High Prevalence of Diabetes Propelling Market Growth – Due to genetic predispositions and unhealthy lifestyle choices, Saudi Arabia has one of the highest prevalence rates in the world. By 2026, around 24% of the total adult population of Saudi Arabia is expected to have Diabetes which was just around 17.7% in 2021. This rising prevalence is leading the nation to become the 2nd highest in the Middle East and 7th highest globally in diabetes occupancy. An unhealthy lifestyle has resulted in the prevalence of obesity-related problems in Saudi Arabia that majorly pose a threat to several chronic diseases like Type-2 diabetes. An approximate 35.4% of the adult population of Saudi Arabia suffers from obesity. This creates an immense nationwide demand for Diabetes Drugs for the treatment and prevention of diabetes, thereby significantly contributing to the market growth.

What is Included in Saudi Arabia Diabetes Drug Market Segmentation?

The report has segmented the market into the following categories:

By Insulins

- Basal- Market Size & Forecast 2020-2030, USD Million

- - Lantus (Insulin Glargine)- Market Size & Forecast 2020-2030, USD Million

- - Levemir (Insulin Detemir)- Market Size & Forecast 2020-2030, USD Million

- - Toujeo(Insulin Glargine)- Market Size & Forecast 2020-2030, USD Million

- - Tresiba(Insulin Degludec)- Market Size & Forecast 2020-2030, USD Million

- - Basaglar (Insulin Glargine) - Market Size & Forecast 2020-2030, USD Million

- Bolous- Market Size & Forecast 2020-2030, USD Million

- - NovoRapid/Novolog (Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million

- - Humalog (Insulin Lispro)- Market Size & Forecast 2020-2030, USD Million

- - Apidra (Insulin Glulisine)- Market Size & Forecast 2020-2030, USD Million

- Traditional Insulins- Market Size & Forecast 2020-2030, USD Million

- - Novolin/ Actrapid/Insulatard- Market Size & Forecast 2020-2030, USD Million

- - Humulin- Market Size & Forecast 2020-2030, USD Million

- - Insuman- Market Size & Forecast 2020-2030, USD Million

- Biosimilar Insulins- Market Size & Forecast 2020-2030, USD Million

- - Insulin Glargine Biosimilars- Market Size & Forecast 2020-2030, USD Million

- - Human Insulin Biosimilars- Market Size & Forecast 2020-2030, USD Million

By Oral Anti-Diabetic Drugs

- Biguanides- Market Size & Forecast 2020-2030, USD Million

- - Metformin- Market Size & Forecast 2020-2030, USD Million

- Alpha-Glucosidase Inhibitors- Market Size & Forecast 2020-2030, USD Million

- Dopamine D2 receptor agonist- Market Size & Forecast 2020-2030, USD Million

- - Bromocriptin- Market Size & Forecast 2020-2030, USD Million

- SGLT-2 Inhibitors- Market Size & Forecast 2020-2030, USD Million

- - Invokana (Canagliflozin)- Market Size & Forecast 2020-2030, USD Million

- - Jardiance (Empagliflozin)- Market Size & Forecast 2020-2030, USD Million

- - Farxiga/Forxiga (Dapagliflozin)- Market Size & Forecast 2020-2030, USD Million

- - Suglat (Ipragliflozin)- Market Size & Forecast 2020-2030, USD Million

- DPP-4 Inhibitors- Market Size & Forecast 2020-2030, USD Million

- - Onglyza (Saxagliptin)- Market Size & Forecast 2020-2030, USD Million

- - Tradjenta (Linagliptin)- Market Size & Forecast 2020-2030, USD Million

- - Vipidia/Nesina(Alogliptin)- Market Size & Forecast 2020-2030, USD Million

- - Galvus (Vildagliptin)- Market Size & Forecast 2020-2030, USD Million

- Sulfonylureas- Market Size & Forecast 2020-2030, USD Million

- Meglitinides- Market Size & Forecast 2020-2030, USD Million

By Non-Insulin Injection Drugs

- GLP-1 Receptor Agonists- Market Size & Forecast 2020-2030, USD Million

- - Victoza (Liraglutide)- Market Size & Forecast 2020-2030, USD Million

- - Byetta (Exenatide)- Market Size & Forecast 2020-2030, USD Million

- - Bydureon (Exenatide)- Market Size & Forecast 2020-2030, USD Million

- - Trulicity (Dulaglutide)- Market Size & Forecast 2020-2030, USD Million

- - Lyxumia (Lixisenatide)- Market Size & Forecast 2020-2030, USD Million

- Amylin Analogue- Market Size & Forecast 2020-2030, USD Million

- - Symlin (Pramlintide)- Market Size & Forecast 2020-2030, USD Million

By Combination Drugs

- Insulin Combinations- Market Size & Forecast 2020-2030, USD Million

- - NovoMix (Biphasic Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million

- - Ryzodeg (Insulin Degludec and Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million

- - Xultophy (Insulin Degludec and Liraglutide)- Market Size & Forecast 2020-2030, USD Million

- Oral Combinations- Market Size & Forecast 2020-2030, USD Million

- - Janumet (Sitagliptin and Metformin)- Market Size & Forecast 2020-2030, USD Million

By Distribution Channel

- Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million

- Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million

- Online Pharmacies- Market Size & Forecast 2020-2030, USD Million

- Clinics and Diabetes Centers- Market Size & Forecast 2020-2030, USD Million

Based on the distribution channel, Hospital Pharmacies lead the Saudi Arabia Diabetes Drugs Market. It holds approx. 40% share of the total global market. This leadership emanates from their position as a central care center for the management of diabetes, especially for severe complications or the use of advanced drugs like insulin and injectables. Specialty care is provided through endocrinologists and diabetes specialists who dispense advanced therapies, mostly available only in these pharmacies. Public hospitals, under the Ministry of Health, distribute essential drugs for diabetes at discounted prices or for free, which makes them more accessible in Saudi Arabia. Hospitals also play an important role in chronic disease management programs, where medication is accompanied by patient education and lifestyle interventions. All these factors contribute to major dependence on hospital pharmacies and make them the most preferable distribution channel.

By Region

- Northern

- Central

- Southern

- Eastern

- Western

-

Access the Complete Report for An In-Depth Analysis - https://www.marknteladvisors.com/research-library/saudi-arabia-diabetes-drug-market.html

Who are the Key Players Operating in the Saudi Arabia Diabetes Drug Industry?

The top companies of the Saudi Arabia Diabetes Drug market ruling the industry are: 

• Novo Nordisk A/S
• Takeda
• Pfizer
• Eli Lilly
• Janssen Pharmaceuticals
• Astellas
• Boehringer Ingelheim
• Merck and Co.
• AstraZeneca
• Julphar
• Bristol Myers Squibb
• Novartis
• Sanofi Aventis

Customize This Report to Fit Your Requirement, We're offering discounts on Purchase of the Report, Get It Today - https://www.marknteladvisors.com/query/request-customization/saudi-arabia-diabetes-drug-market.html

("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")

Key Objectives of Choosing Markntel Advisor’s Report

• Focused Industry Expertise
• Diverse Report Offerings
• Personalized Research Solutions
• Robust Research Methodology
• In-depth Report Coverage
• Tracking Technological Advancements
• Comprehensive Value-Chain Analysis
• Discovering Market Opportunities
• Analyzing Growth Trajectories
• Assured Quality Insights
• Dedicated After-Sales Support
• Trusted by Fortune 500 Companies

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

FAQs (Frequently Ask Questions)

1. What are the industry’s overall statistics or estimates including CARG and USD Value of the forecasting years?
2. What are the trends influencing the current scenario of the Saudi Arabia Diabetes Drug Market?
3. What are the key factors that would propel and hinder the industry?
4. Which geographical area dominates the Saudi Arabia Diabetes Drug industry?
5. Which is the Leading segment in the market?

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Media Inquiries, Please Contact: 

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India